Connect with us

Hi, what are you looking for?

Uncategorized

Japan’s Ajinomoto to buy US-based Forge Biologics for $546 million

© Reuters. Ajinomoto Co. displays the company’s leading product ‘Ajinomoto Monosodium Glutamate Seasoning’ at AJINOMOTO Umami Science Square in Kawasaki, Japan March 18, 2019. REUTERS/Yoshiyasu Shida/File Photo

TOKYO (Reuters) – Japan’s Ajinomoto said on Monday it agreed to acquire U.S.-based genetic medicines maker Forge Biologics Holdings for 82.8 billion yen ($546 million).

The transaction is expected to be completed in December 2023 pending regulatory approvals, Ajinomoto said a release.

($1 = 151.7400 yen)

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube